Roche Diagnostics has a proud tradition of innovation in healthcare around the globe. We are committed to making a real difference in people’s lives by providing products and services for the diagnosis of diseases. One of our objectives is to develop new diagnostic tools to support healthcare professionals and patients, in their efforts to manage diseases and healthcare costs.
Our leadership in innovation is evident in our Early Infant Diagnosis of HIV program built on our globally renowned Polymerase Chain Reaction (PCR) technology. The introduction of a Dried Blood Spot (DBS) sampling option for this program has had a direct benefit for all stakeholders in the healthcare industry namely, patients, clinicians, administrators and program funders.
Roche Diagnostics’ adoption of innovation within these programs is not limited to the development of in-vitrodiagnostic assays for high burden diseases such as HIV/AIDS and TB, but also encompasses other aspects of process workflow in an effort to create sustainable solutions for the challenges posed within resource-limited regions. This is achieved through the AmpliCare Initiative, which was our proactive response to the need to expand diagnostics to these settings.
We are committed to capacity building initiatives through ongoing certified training of laboratory scientists at the Roche PCR Academy in Johannesburg, to ensure highest results, quality and reliability. This training includes education of Health Care Professionals on molecular theory and techniques enabling them to deliver better patient management outcomes.
Through Roche’s research and development initiatives, we also apply our expertise to develop novel solutions, precise and robust diagnostic tests, automated systems and integrated solutions in the fields of Clinical Chemistry, Haematology, Coagulation and Immunodiagnostics.
We believe that through continued effort and investment in the latest innovations in diagnostics, Roche can make a positive, sustainable and cost-effective contribution to developing world healthcare.
Roche Diagnostics is the world leader in in vitro diagnostics. Roche Diagnostics offers a uniquely broad product portfolio and supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories in the fields of diabetes care and anticoagulation therapy, molecular biology, clinical chemistry, immunology and applied science.
Our portfolio includes:
· Blood glucose meters for people with diabetes
· Point-of-care testing devices for use in doctors’ offices
· High-throughput analysers for hospitals and commercial diagnostic laboratories
· State-of-the-art instruments and reagents for life science research